SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TBM700 who wrote (815)4/26/1998 7:32:00 PM
From: Double E   of 4140
 
If you also navigated around the Sunrise home page (while going through Skane's references), then you also read through (hopefully) the following page on FAQ regarding LTK:

sunrise-tech.com

There is one question that specifically addresses the issue of regression. I have not seen any definitive research published by the company on the issue of regression. I am, however, confident that the results of the Sunrise procedure and the LACK of appreciable regression as it is being measured in their trials is a big part of the reason the FDA is moving along so quickly in their review and approval process for the SNRS procedure.

Being a 40+ baby-boomer myself, one question I have always had is: how is regression even defined in a patient whose age bears a direct correlation to the fact that their eyesight is becoming progressively worse every year anyway . . . with or without the Sunrise procedure to correct!

I'm ready to sign up for the treatment as soon as it is approved and accessible. The sooner the better.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext